The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes.

Source:http://linkedlifedata.com/resource/pubmed/id/15860661

Blood 2005 Aug 15 106 4 1207-9

Download in:

View as

General Info

PMID
15860661